The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis.

Source:http://linkedlifedata.com/resource/pubmed/id/17562815

J. Exp. Med. 2007 Jul 9 204 7 1559-69

Download in:

View as

General Info

PMID
17562815